Transplantation of Microencapsulated Cells Expressing VEGF Improves Angiogenesis in Implanted Xenogeneic Acellular Dermis on Wound

Transplantation Proceedings

Volumn 42, Issue 5, 2010, Pages 1935-1943

  Han, Y F ^a   Han, Y Q ^b   Pan, Y G ^c   Chen, Y L ^d   Chai, J K ^a  

^a Burns Institute   (China)

^b WUHAN INSTITUTE OF TECHNOLOGY   (China)

^c The People's Hospital of Qidong city   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL BASED GENE THERAPY; CONTROLLED STUDY; DERMIS; GUINEA PIG; HISTOLOGY; IMMUNE RESPONSE; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; SKIN DEFECT; SURVIVAL RATE; WOUND HEALING;

3T3 CELLS; ANIMALS; DERMIS; DNA PRIMERS; EXTRACELLULAR MATRIX; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC VECTORS; HUMANS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERASE CHAIN REACTION; SKIN TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING; WOUNDS AND INJURIES;

EID: 77953653087     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.12.070     Document Type: Article

References (40)

1. Srivastava A., DeSagun E.Z., Jennings L.J., et al. Use of porcine acellular dermal matrix as a dermal substitute in rats. Ann Surg 233 (2001) 400
2. Bannasch H., Stark G.B., Knam F., et al. Decellularized dermis in combination with cultivated keratinocytes in a short- and long-term animal experimental investigation. J Eur Acad Dermatol Venereol 22 (2008) 41
3. Ge L.P., Zheng S.Q., and Hong W. Comparision of histological structure and biocompatibility between human acellular dermal matrix (ADM) and porcine ADM. Burns 35 (2009) 46
4. Supp D.M., Supp A.P., Bell S.M., et al. Enhanced vascularization of cultured skin substitutes genetically modified to overpress vascular endothelial growth factor. J Invest Dermatol 114 (2009) 5
5. Kusumanto Y.H., van Weel V., Mulder N.H., et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther 17 (2006) 683
6. Yla-Herttuala S., Rissanen T.T., Vajanto I., et al. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 49 (2007) 1015
7. Bao P., Kodra A., Tomic-Canic M., et al. The role of vascular endothelial growth factor in wound healing. J Surg Res 153 (2009) 347
8. Shinzawa H., Takeda A., Sone Y., et al. Wound healing process of a full-thichness skin wound model in rats. Int Surg 92 (2007) 63
9. Cirone P., Potter M., Hirte H., et al. Immuno-isolation in cancer gene therapy. Curr Gene Ther 6 (2006) 181
10. Zhang H., Zhu S.J., Wang W., et al. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther 15 (2008) 40
11. Chang P.L., Shen N., and Westcott A.J. Delivery of recombinant gene products with microencapsulated cells in vivo. Hum Gene Ther 4 (1993) 433
12. Fink D., Mata M., and Glorioso J.C. Cell and gene therapy in the treatment of pain. Adv Drug Deliv Rev 55 (2003) 1055
13. Tai I.T., and Sun A.M. Microencapsulation of recombinant cells: a new delivery system for gene therapy. FASEB J 7 (1993) 1061
14. Lanza R.P., and Chick W.L. Transplantation of encapsulated cells and tissues. Surgery 121 (1997) 1
15. Kastrup J., Jørgensen E., Rück A., et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris: a randomized double-blind placebo controlled study; the Euroinject One Trial. J Am Coll Cardiol 45 (2005) 982
16. Murua A., Orive G., Hernández R.M., et al. Cryopreservation based on freezing protocols for the long-term storage of microencapsulated myoblasts. Biomaterials 30 (2009) 3495
17. Maria-Engler S.S., Mares-Guia M., Correa M.L., et al. Microencapsulation and tissue engineering as an alternative treatment of diabetes. Braz J Med Biol Res 34 (2001) 691
18. Rutanen J., Rissanen T.T., Markkanen J.E., et al. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 109 (2004) 1029
19. Feng X., Pan Y., Tan J., et al. The application of meshed acellular dermis xenograft (pigskin) with split thickness skin autograft in 23 patients. Chin J Plast Surg 16 (2000) 40
20. Wilcke I., Lohmeyer J.A., Liu S., et al. VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo. Langenbecks Arch Surg 392 (2007) 305
21. Yla-Herttuala S., Rissanen T.T., Vajanto I., et al. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 49 (2007) 1015
22. Ozawa C.R., Banfi A., Glazer N.L., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113 (2004) 516
23. Lehrman S. Virus treatment questioned after gene therapy death. Nature 401 (1999) 517
24. Olea F.D., Vera Janavel G., Cuniberti L., et al. Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia. Gene Ther 16 (2009) 716
25. Yau T.M., Fung K., Weisel R.D., et al. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 104 (2001) 1218
26. Penn M.S. Cell-based gene therapy for the prevention and treatment of cardiac dysfunction. Nat Clin Pract Cardiovasc Med 4 (2007) S83
27. Spanholtz T., Maichle A., Niedworok C., et al. Timing and targeting of cell-based VEGF165 gene expression in ischemic tissue. J Surg Res 151 (2009) 153
28. Lee L.Y., Patel S.R., Hackett N.R., et al. Focal angiogenic therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. Ann Thorac Surg 69 (2000) 14
29. Hao J., Yao Y., Varshney R.R., et al. Gene transfer and living release of transforming growth factor-β3 for cartilage tissue engineering applications. Tissue Eng Part C 14 (2008) 273
30. Dickens S., Vermeulen P., Hendrickx B., et al. Regulable vascular endothelial growth factor165 overexpression by ex vivo expanded keratinocyte cultures promotes matrix formation, angiogenesis, and healing in porcine full-thickness wounds. Tissue Eng Part A 14 (2008) 19
31. Lim F., and Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210 (1980) 908
32. Chang T.M. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov 4 (2005) 221
33. Dove A. Cell-based therapies go live. Nat Biotechnol 20 (2002) 339
34. Jones K.S., Sefton M.V., and Gorczynski R.M. In vivo recognition by the host adaptive immune system of microencapsulated xenogeneic cells. Transplantation 78 (2004) 1454
35. Lee R.J., Springer M.L., Blanco-Bose W.E., et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102 (2000) 898
36. Yla-Herttuala S., and Martin J.F. Cardiovascular gene therapy. Lancet 355 (2000) 213
37. Cucchiarini M., and Madry H. Gene therapy for cartilage defects. J Gene Med 7 (2005) 1495
38. Haque T., Chen H., Ouyang W., et al. Investigation of a new microcapsule membrane combining alginate, chitosan, polyethylene glycol and poly-l-lysine for cell transplantation applications. Int J Artif Organ 28 (2005) 631
39. Dusseault J., Tam S.K., Menard M., et al. Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination. J Biomed Mater Res A 76 (2005) 243
40. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664